Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM8124R)

Drug Name
INCB01158 Drug Info
Synonyms CB-1158
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1/2 [1]
Cross-matching ID
TTD Drug ID
DM8124R

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Arginase (ARG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BCT-100 DMZK7IT Solid tumour/cancer 2A00-2F9Z Phase 1/2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Arginase (ARG) TTSANDR ARGI1_HUMAN; ARGI2_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT03837509) INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.